Stock Ratings / Health Care / TFX / financials

MMSI (75) HAE (74) MMED (46) HTFL (53) ⌘ Pro Terminal →

Teleflex Incorporated (TFX) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$141.39 +1.73% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Teleflex Incorporated (TFX) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $5.99B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-4.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for TFX)Realized 20D OHLCV Swing Band: ±5.7%

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How TFX Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$30.0M (1.5% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $1.71B

FY24

Rev $1.70B

FY25

Rev $1.99B

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$1.99B	56.2%	5.9%	-$905.6M	-$860.4M	1.8%
FY 2024	$1.70B	61%	6.1%	$70.2M	$66.7M	1.5%
FY 2023	$1.71B	56.2%	15.1%	$357.6M	$339.7M	10.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring TFX)

✓Walkthrough of TFX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

TFX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +17.93%📐 HORIZONTAL RANGE

2026-11-01O $139.0H $141.4L $139.0C $141.4VOL 838.0K

RES: $153.6SUP: $113.5SMA50: $131.4SMA200: $125.3

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TFX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 TFX Butterfly Map → + Track TFX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

20.6%/yr Implied 5Y Growth

vs. +17.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on TFX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TFX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for TFX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (TFX)

Health Care Rank #156 of 188 ⚔️ MMSI vs TFX Full Matrix →

1. Head-to-Head Health Care Peer Comparison (TFX vs. MMSI, HAE, MMED, HTFL)

Industry: Medical/Dental Instruments (21 Tracked Issuers)

Across 188 tracked Health Care securities in the Roarable RQD universe, Teleflex Incorporated (TFX) ranks #156 by composite RQD confidence (48/100, grade D) and #146 by equity capitalization ($5.99B). Within this direct 5-issuer industry benchmark cohort, MMSI leads on earnings valuation at 43.4x trailing P/E, while HAE leads on capital efficiency and profitability with 8.4% ROIC and 59.0% gross margin. MMSI currently holds the highest overall quantitative score in the immediate peer group at 75/100 (B) compared with TFX at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
TFX ACTIVE Teleflex Incorporated	D	48/100	—	56.2%	1.8%	+1.73%	$5.99B	Benchmark Subject
MMSI Merit Medical Systems Inc.	B	75/100	43.4x	48.7%	7.8%	+1.28%	$5.58B	/mmsi-vs-tfx →
HAE Haemonetics Corporation	B	74/100	—	59.0%	8.4%	+1.24%	$5.45B	/hae-vs-tfx →
MMED MiniMed Group Inc.	D	46/100	—	54.2%	-3.9%	+0.21%	$5.42B	/mmed-vs-tfx →
HTFL Heartflow Inc.	D+	53/100	—	76.8%	-12.0%	+2.42%	$5.26B	/htfl-vs-tfx →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000096943

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Teleflex Incorporated (TFX) reported GAAP revenue of $1.99B (+17.2% vs. FY2024 revenue of $1.70B , and +16.4% cumulative change since FY2023) , GAAP net income of -$905.6M, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, TFX closed FY2025 with $6.95B in total assets against $2.54B in total debt (Altman Z-Score: 2.12, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.99B	-$905.6M	—	—	$6.95B	$2.54B
FY2024 (FY)	2024-12-31	$1.70B	$70.2M	—	—	$7.10B	$1.56B
FY2023 (FY)	2023-12-31	$1.71B	$357.6M	—	—	$3.30B	$771.0M

3. TFX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is TFX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Teleflex Incorporated (NYSE: TFX) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $141.39 (+1.73% 1D, market cap $5.99B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 5/20. Active quantitative signal LIQUIDITY_TAILWIND (BULLISH, conviction undefined/100) notes: undefined.

How does TFX compare to MMSI and HAE in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), TFX carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 56.2%, and ROIC of 1.8%. By comparison, MMSI (Merit Medical Systems Inc.) holds a B grade (75/100 RQD, P/E 43.4x, ROIC 7.8%, cap $5.58B) and HAE (Haemonetics Corporation) posts a B grade (74/100 RQD, P/E N/A, ROIC 8.4%, cap $5.45B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for TFX?

Per TFX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000096943), Teleflex Incorporated generated $1.99B in revenue (+17.2% YoY), -$905.6M in net income, and $0 in free cash flow against $6.95B in total assets and $2.54B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is TFX trading relative to its 50-day, 200-day, and 52-week technical levels?

TFX last traded at $141.39 (+1.73% on volume of 838,012 shares), positioning the stock +7.61% above its 50-day simple moving average ($131.39) and +12.81% above its 200-day simple moving average ($125.34). Across its 52-week range of $100.18 to $145.00, TFX sits at the 91.9% percentile with a 14-day RSI of 70.2 (OVERBOUGHT (>70)) and an implied next-earnings move of ±5.7% ($133.33 to $149.45).

TFX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is Teleflex Incorporated (TFX)?

In FY 2025 (10-K), TFX converted $2.0B of revenue into a 56.2% gross margin, 5.9% operating margin, and $30.0M in free cash flow (1.5% FCF margin).

Direct Sub-Reports: TFX RQD Cockpit TFX 12M Forecast TFX Earnings & Move TFX Dividends & DRIP TFX Insiders & 13F TFX Whale Options TFX Profit Sankey TFX News & Why